Social media and pharmacovigilance: A review of the opportunities and challenges

Authors:

Abstract
Adverse drug reactions come at a considerable cost on society. Social media are a potentially invaluable reservoir of information for pharmacovigilance, yet their true value remains to be fully understood. In order to realize the benefits social media holds, a number of technical, regulatory and ethical challenges remain to be addressed. We outline these key challenges identifying relevant current research and present possible solutions.
Funding Information
  • European Union's Seventh Framework Programme (FP7/2007-2013)

This publication has 45 references indexed in Scilit: